Risk factors, such as myometrial invasion, serosal involvement, lymph-vascular space invasion (LVSI), GREB1-NCOA2 fusion, NCOA2 or NCOA3 [23, 41, 42], and high mitotic activity [40, 43]have been proven to be associated with tumor recurrence. This evidence concerns the gene NCOA3 and neoplasm.